Cochlear | Stammkapital

Aktienkurs
250.17
Täglich Wechseln
-8.57 -3.31%
Monatlich
-4.74%
Jährlich
-19.25%
Q1 Prognose
245.14




Stammkapital Veränderung Datum
Ansell USD 1.03B 305.2M 2024-06
Cochlear AUD 1.18B 19.2M 2024-12
CSL USD 576M 19M 2024-12
Fisher Paykel Healthcare NZD 587.25M 1.35M 2025-12
Healius AUD 2.6B 100K 2024-12
Integral Diagnostics AUD 335.09M 1.07M 2024-06
Mayne Pharma AUD 81.25M 0 2025-06
Mesoblast USD 1.28B 127.49M 2025-06
Monash IVF AUD 506.79M 0 2024-12
Nanosonics AUD 114.74M 192K 2024-12
Polynovo AUD 191.6M 0 2024-06
Ramsay Health Care AUD 2.27B 19.6M 2024-12
Regis Healthcare AUD 275.27M 1.18M 2024-12
ResMed USD 145.66M 144.9M 2025-12
Sigma Healthcare AUD 11.5B 9.93B 2025-12
Sonic Healthcare AUD 4.15B 467K 2024-12
Telix Pharmaceuticals AUD 587.41M 141.14M 2024-06


Cochlear Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.